Guidant Fights Plaintiffs' Bid For Sanctions

Law360, New York (July 2, 2007, 12:00 AM EDT) -- On the eve of the first bellwether trial over Guidant Corp.'s allegedly defective implantable heart defibrillators, the medical device maker has lashed out at the plaintiffs' bid to sanction one of Guidant's nonretained expert witnesses, calling the move “a baseless and unprofessional attack.”

Guidant—which was acquired by Boston Scientific Corp. last year—said in court documents filed June 29 that the court should deny the plaintiffs' motion for sanctions regarding Dr. Stephen Higgins, arguing that the request is a “last-ditch, desperate attempt to lodge groundless ethical complaints...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.